How has The Joint Corp.'s clinic licenses sold but not yet developed changed year-over-year?

The Joint Corp.'s clinic licenses sold but not yet developed decreased by 39.4% year-over-year, from 94 to 57.

The Joint Corp. JYNT Clinic licenses sold but not yet developed

Revenue$14.8M+13.3%

Gross profit$12.1M+19.7%

Operating income$873.7K+229%

Net income$1.3M+34.2%

EPS (diluted)$0.09+50.0%

Cash & equivalents$21.4M-6.4%

Total debt$2.0M-9.3%

Total equity$15.5M-22.3%

Total assets$57.9M-25.0%

Operating cash flow-$1.5M+60.1%

CapEx$234.6K-29.2%

Free cash flow-$1.7M+57.6%

Market cap$127.87M-28.0%

Enterprise value$108.49M-27.1%

P/E39.5×—

P/S2.3×-0.2×

Gross margin80.6%-6.0pp

Operating margin1.1%+0.7pp

Net margin5.7%+3.7pp

FCF margin7.2%-0.4pp

Return on equity18.3%+11.6pp

Debt / equity0.1×0.0×

Current ratio1.6×+0.1×

Reported directly by The Joint Corp. in its filing.

Tagged under the XBRL concept jynt:ClinicLicensesSoldButNotYetDeveloped.

The official record: The Joint Corp.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is The Joint Corp.'s clinic licenses sold but not yet developed?: The Joint Corp. (JYNT) reported clinic licenses sold but not yet developed of 57 in Q1 2026.
How has The Joint Corp.'s clinic licenses sold but not yet developed changed year-over-year?: The Joint Corp.'s clinic licenses sold but not yet developed decreased by 39.4% year-over-year, from 94 to 57.